Genmab — Juli 2020
-
Jan
track record er fænomenal. Så når han siger sådan, så er det -
meget stor sandsynlighed for at der er mere at vente meget snart
-
sikkert allerede til efteråret, med PD-L1x41BB
-
Ja, du vil jo gerne være pessimist, du troede heller på partneraftale før halvårsskiftet...
-
Nu er det jo kliniske data der kommer på denne senere i år
-
Genmab har allerede set virkninger der sætter alle eksisterende PD-L1 blokkere på plads
-
God morgen.

-
Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety
run-in results of ANDROMEDA http://ow.ly/tRUq50ArROO -
-

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind